Specificity of radioiodinated MIBG for neural crest tumors in childhood

Journal of Nuclear Medicine

Volumn 38, Issue 9, 1997, Pages 1352-1357

  Leung, Ann ^b   Shapiro, Brahm ^a   Hattner, Robert ^b   Kim, Esther ^b   De Kraker, Jan ^b   Ghazzar, Nadia ^b   Hartmann, Olivier ^b   Hoefnagel, Cornelius A ^b   Jamadar, David A ^b   Kloos, Richard ^b   Lizotte, Paul ^b   Lumbroso, Jean ^b   Rufini, Vittoria ^b   Shulkin, Barry L ^b   Sisson, James C ^b   Thein, Aung ^b   Troncone, Luigi ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b NONE

Author keywords

Childhood tumors; Metaiodobenzylguanidine; Neural crest tumors; Specificity

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG SPECIFICITY; DRUG UPTAKE; FEMALE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEURAL CREST; NEUROBLASTOMA; NEUROECTODERM TUMOR; NEWBORN; PHEOCHROMOCYTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; SCHOOL CHILD;

3-IODOBENZYLGUANIDINE; ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; IODINE RADIOISOTOPES; IODOBENZENES; MALE; NEUROBLASTOMA; PHEOCHROMOCYTOMA; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0030884471     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Geatti O, Shapiro B, Sisson JC, et al. Iodine-131-metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases. J Nucl Med 1985;26:736-742.
2. Hoefnagel CA, Voûte PA, De Kraker J, et al. Radionuclide diagnosis and therapy of neural crest tumors using iodine-131-metaiodobenzylguanidine. J Nucl Med 1987;28: 308-314.
3. Shapiro B, Copp JE, Sisson JC, et al. Iodine-131-metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 1985;26:576-585.
4. Troncone L, Rufini V, Montemaggi P, et al. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). Eur J Nucl Med 1990;16:325-335.
5. Hoefhagel CA. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumors. Eur J Nucl Med 1994;21:561-581.
6. Gelfand MJ. Metaiodobenzylguanidine in children. Semin Nucl Med 1993;23:231-242.
7. Lastoria S, Maurea S, Caraco C, et al. Iodine-131-metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: comparison with computed tomography and ultrasonography. Eur J Nucl Med 1993;20:1161-1167.
8. Von Moll L, McEwan AJ, Shapiro B, et al. Iodine-131-MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma. J Nucl Med 1987;28:979-988.
9. Hadley GP, Rabe E. Scanning with iodine-131-MIBG in children with solid tumors: an initial appraisal. J Nucl Med 1986;21:620-626.
10. Jacobs A, Delree M, Desprechins B, et al. Consolidating the role of *iodine-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience. Pediatr Radial 1990;20:157-159.
11. Endo K, Shiomi K, Kasagi K, et al. Imaging of medullary thyroid carcinoma with iodine-131-MIBG. Lancet 1984;2:233.
12. Fischer M, Kamanabroo D, Sonderkamp H, et al. Scintigraphic imaging of carcinoid tumors with iodine-131-metaiodobenzylguanidine. Lancet 1984;2:165.
13. Hayward RS, Bowering K, Warshawski RS. Iodine-131-metaiodobenzylguanidine uptake in a parathyroid adenoma. Clin Nucl Med 1988;13:632-634.
14. Stewart RE, Grossman DM, Shulkin BL, Shapiro B. Iodine-131-metaiodobenzylguanidine uptake in infantile myofibromatosis. Clin Nucl Med 1989;14:344-346.
15. Tobes MC, Jaques S, Wieland DM, et al. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med 1984;26:897-907.
16. Guilloteau D, Baulieu JL, Huguet F, et al. Metaiodobenzylguanidine adrenal medulla localization: autoradiographic and pharmacologic studies. Eur J Nucl Med 1984;9: 278-281.
17. Wafelman AR, Hoefnagel CA, Macs RAA, et al. Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry. Eur J Nucl Med 1994;21:545-559.
18. Jaques S, Tobes MC, Sisson JC, et al. Comparison of the sodium dependency of uptake of metaiodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells. Mol Pharmacol 1984;25:539-546.
19. 125l)iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH. Cancer Res 1985;45:6366-6370.
20. Jaques S, Tobes MC, Sisson JC. Sodium dependency of uptake of norepmephrine and metaiodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one. Cancer Res 1987;47:3920-3928.
21. Smets LA, Loesberg C, Janssen M, et al. Active uptake and extravesicular storage of metaiodobenzylguanidine in human neuroblastoma SK-N-SH cells. Cancer Res 1989;49:2941-2944.
22. Horne T, Glaser B, Krausz Y, et al. Unusual causes of iodine-131-metaiodobenzylguanidine uptake in non-neural crest tissue. Clin Nucl Med 1991;16:239-242.
23. Treuner J, Klingebiel T, Bruchelt G, et al. Treatment of neuroblastoma with metaiodobenzylguanidine: results and side effects. Med Pediatr Oncol 1987;15:199-202.
24. Hartmann O, Lumbroso J, Lemerle J, et al. Therapeutic use of iodine-131-metaiodobenzylguanidine (MIBG) in neuroblastoma: a phase II study in nine patients. Med Pediatr Oncol 1987;15:205-211.
25. Hoefnagel CA, Voûte PA, De Kraker J, et al. Iodine-131-metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma. J Nucl Biol Med 1992;35:202-206.
26. Hoefnagel CA, De Kraker J, Valdes Olmos RA, Voûte PA. Iodine-131-metaiodobenzylguanidine as a first-line treatment in high risk neuroblastoma patients. Nucl Med Comm 1994;15:712-717.
27. Schmiegelow K, Siimes MA, Agertoft L, et al. Radio-iodobenzylguanidine scintigraphy of neuroblastoma: conflicting results, when compared with standard investigations. Med Pediatr Oncol 1989;17:126-130.
28. Bomanji J, Hungerford JL, Kingston JE, et al. Iodine-123-metaiodobenzylguanidine (MIBG) scintigraphy of retinoblastoma: preliminary experience. Br J Ophthalmol 1989;73:146-150.
29. Geatti O, Shapiro B, Barillari B. Scintigraphic depiction of an insulinoma by iodine-131-metaiodobenzylguanidine. Clin Nucl Med 1989;14:903-905.
30. Khafagi F, Shapiro B, Fischer M, et al. Pheochromocytomas and functioning paraganglioma in childhood and adolescence: role of iodine-131-metaiodobenzylguanidine. Eur J Nucl Med 1991;18:191-198.
31. Bomanji J, Kingston JE, Hungerford JL, et al. Iodine-123-metaiodobenzylguanidine scintigraphy of ectopic intracranial retinoblastoma. Med Pediatr Oncol 1989;17:66-68.
32. 123I-metaiodobenzylguanidine imaging in Ewing's sarcoma of bone. Med Pediatr Oncol 1994;23:130-132.
33. Feggi L, Uberti E, Pansini G, et al. Pitfalls in scintigraphic detection of neuroendocrine tumors. Eur J Nucl Med 1992;19:214-218.
34. Saint-Andre JP, Chapeau MC, Pein F. Nephroblastoma with neuronal symptomatic differentiation. Ann Pathol 1988;8:144-148.
35. Muino Miguez A, Robles Perez R, Lopez Gomez JM, et al. Falso positivo con MIBG en la localizacion del feocromocitoma. Medicina Clin 1986;86:437.
36. Jacobs A, Lenoir P, Delree M, et al. Unusual technetium-99m MDP and iodine-123-metaiodobenzylguanidine images in focal pyelonephritis. Clin Nucl Med 1990;15:821-824.
37. Bahar RH, Mahmoud S, Ibrahim A, et al. A false positive iodine-131-metaiodobenzylguanidine due to dilated renal pelvis: a case report. Clin Nucl Med 1988;13:900-902.
38. Manil L, Edeline V, Lumbroso J, Lequen H, Zucker J-M. Indium-111-pentreotide scintigraphy in children with neuroblast-derived tumors. J Nucl Med 1996;37:893-896.